Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-06

Clinical Trial Update: Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing leuprolide acetate or goserelin acetate against observation in high-risk prostate cancer patients after radical prostatectomy; study t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Goserelin acetate (goserelin)
  • Leuprolide acetate (Leuprolide acetate)

Snippet

Sponsor: Mayo Clinic | Conditions: Prostate Adenocarcinoma, Stage IIA Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2013-12-06